Skip to main content

OpenAI Under US Regulator Probe for Potential Consumer Harm by ChatGPT

OpenAI Under US Regulator Probe for Potential Consumer Harm by ChatGPT

The United States Federal Trade Commission, an independent agency of the United States government, is looking into OpenAI to see if its massively popular ChatGPT app harms consumers by providing incorrect information and if its technology mishandles user data.

The United States probe was reportedly announced to Microsoft-backed OpenAI in a 20-page questionnaire, in which the firm is requested to describe events wherein users were wrongly disparaged. 

The Washington Post,  an American daily newspaper published in Washington, D.C, was the first to report on the US regulator's probe. The introduction of ChatGPT by OpenAI last November astounded the world by demonstrating the capabilities of large language models (or LLM), a type of artificial intelligence known as generative AI that can generate human-like content in just a second.

On Wednesday, FTC Chair Lina Khan spoke before a congressional committee. During the event, she did not mention the US investigation, however, she told lawmakers that her agency was concerned about ChatGPT's possibly libelous output.

ChatGPT received a lot of attention earlier this year for its rapid development, and it was dubbed the fastest-growing program. Within two months, it was projected that it had achieved over 100 million active monthly users.

ChatGPT makes the majority of its money by selling APIs and plugins to businesses. Nowadays big companies and businesses are willing to pay through the roof for OpenAI's plugins after seeing what GPT-4 and GPT3.5 are capable of.

According to reports, ChatGPT has encountered various difficulties, including inaccurate answers and the implementation of specific subject limits. These issues, together with the availability of alternative AI tools, may contribute to a drop in user numbers. Earlier, the Washington Post also reported about the decrease in number of users. 

Artificial intelligence (AI) has the potential to be employed in a wide range of fields where intelligence is already used.


Comments

Popular posts from this blog

Netanyahu’s Shocking Gaza Plan: ‘We Will Take Control of ALL of Gaza’ — But At What Cost?

  As Israeli forces intensify their offensive, Netanyahu vows total control of Gaza — but the humanitarian crisis is reaching a breaking point. Will the world stand by and watch? Israeli Prime Minister Benjamin Netanyahu has declared that Israel will “take control of all” of the Gaza Strip, signaling an unprecedented escalation in the ongoing conflict. In a video posted to Telegram, Netanyahu emphasized that military operations are advancing rapidly, with no intention of backing down. “The fighting is intense, and we are making progress,” he said, framing the offensive as necessary for Israel’s long-term security. But as international pressure mounts, his government is walking a tightrope between military dominance and global condemnation. The Israeli military has ordered mass evacuations in southern Gaza, warning residents of Khan Yunis and surrounding areas to flee immediately ahead of a devastating assault. Arabic-language spokesman Avichay Adraee described the coming attack as ...

Israel issues latest forced evacuation order in areas in Khan Younis

  The Israeli army’s Arabic-language spokesperson, Avichay Adraee, has issued the latest forced evacuation order for civilians living in nine areas in Khan Younis, southern Gaza. Adraee said that the army was expanding its operation and “intensifying sudden and concentrated firepower”. The spokesperson called on residents to evacuate westward. So-called Israeli safe zones, including Al-Mawasi in Khan Younis, are routinely attacked despite the army forcing Palestinians to move to those areas.

UAE initiates extensive CAR T-cell treatment in the region

The United Arab Emirates has transformed the medical structure of the region as it slowly moves towards attaining leadership in medical treatments and complex procedures. It has stepped up on the list with a pioneering treatment led by Abu Dhabi. The capital has witnessed a revolutionary process that focuses on the safety and efficacy of using the CAR T-Cell treatment module especially for hematologic or blood cancers such as lymphoma, myeloma, and certain types of leukemia. This is an exemplary step in the context of the region as it is the first of its kind treatment here.  On Saturday, the Emirati nation began its experiment to locally manufacture CAR T-Cell treatment at Abu Dhabi Stem Cells Center. The T-Cells will be locally reprogrammed and tested for their effectiveness so that they get better results when it comes to treating cancer.   The unit for the stem cell treatment ADSCC was founded in 2019 and since then it has grown threefold when it comes to experimenting wit...